BSE filing, NSE: SAHLIBHFI. Summary written from the filing by ALFA Finder's alert engine.
Shalibhadra Finance Ltd: key numbers
- Share price
- ₹70.61
- Market cap
- ₹218.1 Cr
- Revenue (annual)
- ₹41.05 Cr
- Net profit (annual)
- ₹19.48 Cr
- P/E (TTM)
- 11.0×Sector 19.7×
- Promoter holding
- 58.10%+0.00% QoQ
- FII holding
- 0.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shalibhadra Finance Ltd
All →Shalibhadra Finance Management Change
Shalibhadra Finance submitted the resignation letter of its Company Secretary, Megha Singh, which was omitted from the initial announcement. The departure was effective October 1, 2026.
Shalibhadra Finance Debt & Borrowing: ₹24 Cr
Shalibhadra Finance Limited's board approved issuing secured non-convertible debentures worth up to ₹24 Crore on a private placement basis.
- Value
- ₹24.00 Cr
Shalibhadra Finance Debt & Borrowing: ₹4.88 Cr
Shalibhadra Finance Ltd redeemed partial face value of its non-convertible debentures, amounting to ₹4.88 Crore. The payment was completed on October 10, 2026.
- Value
- ₹4.88 Cr
Shalibhadra Finance Debt & Borrowing: ₹0.19 Cr
Shalibhadra Finance Ltd paid Rs.0.19 Crore as interest for its debt securities. This payment aligns with its scheduled debt obligations.
- Value
- ₹0.19 Cr
Shalibhadra Finance Debt & Borrowing
Shalibhadra Finance Limited submitted its half-yearly statement of outstanding ISINs for non-convertible debentures as of 30th September, 2026, as required by SEBI regulations.
Shalibhadra Finance Board Meeting Date
Shalibhadra Finance has scheduled a board meeting on October 13, 2026, to consider issuing non-convertible debentures on a private placement basis.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.